QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer 期刊论文 2019, 卷号: 118, 页码: 169-177 作者:  Huober, Jens;  Holmes, Eileen;  Baselga, Jose;  de Azambuja, Evandro;  Untch, Michael 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 Breast cancer  HER2 positive  Neoadjuvant   Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients 期刊论文 2019, 卷号: 111, 期号: 1, 页码: 86-94 作者:  Lambertini, Matteo;  Campbell, Christine;  Bines, Jose;  Korde, Larissa A.;  Izquierdo, Miguel 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial 期刊论文 2017, 卷号: 35 作者:  Huober, Jens Bodo;  Holmes, Eileen McCormick;  Baselga, Jose;  De Azambuja, Evandro;  Untch, Michael 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Huober, Jens Bodo;  Holmes, Eileen McCormick;  Baselga, Jose;  De Azambuja, Evandro;  Untch, Michael 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04 Updated results from the phase III ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L) or their combination (L plus T) in the adjuvant tre 期刊论文 2017, 卷号: 35 作者:  Moreno-Aspitia, Alvaro;  Holmes, Eileen McCormick;  Jackisch, Christian;  De Azambuja, Evandro;  Boyle, Frances M. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial 期刊论文 2016, 卷号: 108, 期号: 8 作者:  Sonnenblick, Amir;  de Azambuja, Evandro;  Agbor-tarh, Dominique;  Bradbury, Ian;  Campbell, Christine 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial 期刊论文 2016, 卷号: 34, 期号: 10, 页码: 1034-+ 作者:  Piccart-Gebhart, Martine;  Holmes, Eileen;  Baselga, Jose;  de Azambuja, Evandro;  Dueck, Amylou C. 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04 First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination (T plus L) in the adjuvant trea 期刊论文 2014, 卷号: 32, 期号: 18 作者:  Piccart-Gebhart, Martine J.;  Holmes, Andrew Peter;  Baselga, Jose;  De Azambuja, Evandro;  Dueck, Amylou C. 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13 First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination T plus L) in the adjuvant treat 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20 作者:  Piccart-Gebhart, Martine J.;  Holmes, Andrew Peter;  Baselga, Jose;  De Azambuja, Evandro;  Dueck, Amylou C. 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13